 | • レポートコード：QYR9ST04408 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、がん免疫療法の世界市場について調査・分析し、がん免疫療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（モノクローナル抗体、がんワクチン、チェックポイント阻害剤、免疫調節薬）、用途別（肺、乳房、結腸直腸、黒色腫、前立腺、頭頸部）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のがん免疫療法市場動向 ・主要企業別マーケットシェア ・がん免疫療法の種類別市場規模2014-2019 （モノクローナル抗体、がんワクチン、チェックポイント阻害剤、免疫調節薬） ・がん免疫療法の用途別市場規模2014-2019 （肺、乳房、結腸直腸、黒色腫、前立腺、頭頸部） ・がん免疫療法の北米市場：主要企業・種類別/用途別市場規模 ・がん免疫療法のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・がん免疫療法の中国市場：主要企業・種類別/用途別市場規模 ・がん免疫療法の日本国内市場：主要企業・種類別/用途別市場規模 ・がん免疫療法の東南アジア市場：主要企業・種類別/用途別市場規模 ・がん免疫療法のインド市場：主要企業・種類別/用途別市場規模 ・がん免疫療法の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Amgen、Bristol Mayer’s Squibb、F. Hoffmann-La Roche、Merck、Takeda） ・がん免疫療法の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Cancer immunotherapy is a type of cancer treatment that boosts the human bodys natural immune system to fight against the cancer cells. This therapy is provided to cancer patients to stop the spread of cancer, to slow down the growth of cancer cells, and to improve the natural immunity for destroying the cancer cells.Rising R&D in cancer immunotherapy is resulting in introduction of advanced treatment options that are more effective and efficient. A paradigm shift from traditional chemotherapies to immunotherapies is propelling the overall market.
The world cancer immunotherapy market is foretold to gain impetus due to rising popularity of patient assistance programs and broad portfolio of promising pipeline drugs. However, there could be more significant factors augmenting the demand in the market. For instance, rise in requirement of cancer monoclonal antibodies and launch of more effective bioinformatics tools offering improved drug development options could help with more demand for cancer immunotherapy. Furthermore, surge in adoption of immunotherapy therapeutics compared to conventional ones and high incidence of cancer could help the market to increase growth in the coming years.
The Americas accounted for approximately 47% of the market share of the global cancer immunotherapies market in 2015. High incidences of cancer in regions like the US, Canada, and Latin America are expected to contribute to the market growth in this region. region. This has led to an increase in consumption of immunotherapies that is used to treat cancer patients, thereby aiding the market growth.
In 2018, the global Cancer Immunotherapies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Cancer Immunotherapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Immunotherapies development in United States, Europe and China.
The key players covered in this study
Amgen
Bristol Mayer’s Squibb
F. Hoffmann-La Roche
Merck
Takeda
…
Market segment by Type, the product can be split into
Monoclonal Antibodies
Cancer Vaccines
Check Point Inhibitors
Immunomodulators
Market segment by Application, split into
Lung
Breast
Colorectal
Melanoma
Prostate
Head & Neck
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Cancer Immunotherapies status, future forecast, growth opportunity, key market and key players.
To present the Cancer Immunotherapies development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Cancer Immunotherapies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Immunotherapies Market Size Growth Rate by Type (2014-2025)
1.4.2 Monoclonal Antibodies
1.4.3 Cancer Vaccines
1.4.4 Check Point Inhibitors
1.4.5 Immunomodulators
1.5 Market by Application
1.5.1 Global Cancer Immunotherapies Market Share by Application (2014-2025)
1.5.2 Lung
1.5.3 Breast
1.5.4 Colorectal
1.5.5 Melanoma
1.5.6 Prostate
1.5.7 Head & Neck
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Cancer Immunotherapies Market Size
2.2 Cancer Immunotherapies Growth Trends by Regions
2.2.1 Cancer Immunotherapies Market Size by Regions (2014-2025)
2.2.2 Cancer Immunotherapies Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Cancer Immunotherapies Market Size by Manufacturers
3.1.1 Global Cancer Immunotherapies Revenue by Manufacturers (2014-2019)
3.1.2 Global Cancer Immunotherapies Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cancer Immunotherapies Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Immunotherapies Key Players Head office and Area Served
3.3 Key Players Cancer Immunotherapies Product/Solution/Service
3.4 Date of Enter into Cancer Immunotherapies Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Cancer Immunotherapies Market Size by Type (2014-2019)
4.2 Global Cancer Immunotherapies Market Size by Application (2014-2019)
5 United States
5.1 United States Cancer Immunotherapies Market Size (2014-2019)
5.2 Cancer Immunotherapies Key Players in United States
5.3 United States Cancer Immunotherapies Market Size by Type
5.4 United States Cancer Immunotherapies Market Size by Application
6 Europe
6.1 Europe Cancer Immunotherapies Market Size (2014-2019)
6.2 Cancer Immunotherapies Key Players in Europe
6.3 Europe Cancer Immunotherapies Market Size by Type
6.4 Europe Cancer Immunotherapies Market Size by Application
7 China
7.1 China Cancer Immunotherapies Market Size (2014-2019)
7.2 Cancer Immunotherapies Key Players in China
7.3 China Cancer Immunotherapies Market Size by Type
7.4 China Cancer Immunotherapies Market Size by Application
8 Japan
8.1 Japan Cancer Immunotherapies Market Size (2014-2019)
8.2 Cancer Immunotherapies Key Players in Japan
8.3 Japan Cancer Immunotherapies Market Size by Type
8.4 Japan Cancer Immunotherapies Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Cancer Immunotherapies Market Size (2014-2019)
9.2 Cancer Immunotherapies Key Players in Southeast Asia
9.3 Southeast Asia Cancer Immunotherapies Market Size by Type
9.4 Southeast Asia Cancer Immunotherapies Market Size by Application
10 India
10.1 India Cancer Immunotherapies Market Size (2014-2019)
10.2 Cancer Immunotherapies Key Players in India
10.3 India Cancer Immunotherapies Market Size by Type
10.4 India Cancer Immunotherapies Market Size by Application
11 Central & South America
11.1 Central & South America Cancer Immunotherapies Market Size (2014-2019)
11.2 Cancer Immunotherapies Key Players in Central & South America
11.3 Central & South America Cancer Immunotherapies Market Size by Type
11.4 Central & South America Cancer Immunotherapies Market Size by Application
12 International Players Profiles
12.1 Amgen
12.1.1 Amgen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cancer Immunotherapies Introduction
12.1.4 Amgen Revenue in Cancer Immunotherapies Business (2014-2019)
12.1.5 Amgen Recent Development
12.2 Bristol Mayer’s Squibb
12.2.1 Bristol Mayer’s Squibb Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cancer Immunotherapies Introduction
12.2.4 Bristol Mayer’s Squibb Revenue in Cancer Immunotherapies Business (2014-2019)
12.2.5 Bristol Mayer’s Squibb Recent Development
12.3 F. Hoffmann-La Roche
12.3.1 F. Hoffmann-La Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cancer Immunotherapies Introduction
12.3.4 F. Hoffmann-La Roche Revenue in Cancer Immunotherapies Business (2014-2019)
12.3.5 F. Hoffmann-La Roche Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cancer Immunotherapies Introduction
12.4.4 Merck Revenue in Cancer Immunotherapies Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Takeda
12.5.1 Takeda Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cancer Immunotherapies Introduction
12.5.4 Takeda Revenue in Cancer Immunotherapies Business (2014-2019)
12.5.5 Takeda Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Cancer Immunotherapies Key Market Segments
Table Key Players Cancer Immunotherapies Covered
Table Global Cancer Immunotherapies Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Cancer Immunotherapies Market Size Market Share by Type 2014-2025
Figure Monoclonal Antibodies Figures
Table Key Players of Monoclonal Antibodies
Figure Cancer Vaccines Figures
Table Key Players of Cancer Vaccines
Figure Check Point Inhibitors Figures
Table Key Players of Check Point Inhibitors
Figure Immunomodulators Figures
Table Key Players of Immunomodulators
Table Global Cancer Immunotherapies Market Size Growth by Application 2014-2025 (Million US$)
Figure Lung Case Studies
Figure Breast Case Studies
Figure Colorectal Case Studies
Figure Melanoma Case Studies
Figure Prostate Case Studies
Figure Head & Neck Case Studies
Figure Cancer Immunotherapies Report Years Considered
Table Global Cancer Immunotherapies Market Size 2014-2025 (Million US$)
Figure Global Cancer Immunotherapies Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Cancer Immunotherapies Market Size by Regions 2014-2025 (Million US$)
Table Global Cancer Immunotherapies Market Size by Regions 2014-2019 (Million US$)
Table Global Cancer Immunotherapies Market Share by Regions 2014-2019
Figure Global Cancer Immunotherapies Market Share by Regions 2014-2019
Figure Global Cancer Immunotherapies Market Share by Regions 2019
Table Market Top Trends
Table Global Cancer Immunotherapies Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Cancer Immunotherapies Market Share by Manufacturers (2014-2019)
Figure Global Cancer Immunotherapies Market Share by Manufacturers in 2018
Table Global Cancer Immunotherapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Cancer Immunotherapies Product/Solution/Service
Table Date of Enter into Cancer Immunotherapies Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Cancer Immunotherapies Market Size by Type (2014-2019) (Million US$)
Table Global Cancer Immunotherapies Market Size Share by Type (2014-2019)
Figure Global Cancer Immunotherapies Market Size Market Share by Type (2014-2019)
Table Global Cancer Immunotherapies Market Size by Application (2014-2019) (Million US$)
Table Global Cancer Immunotherapies Market Size Share by Application (2014-2019)
Figure Global Cancer Immunotherapies Market Size Market Share by Application (2014-2019)
Figure Global Cancer Immunotherapies Revenue Market Share by Application in 2018
Figure United States Cancer Immunotherapies Market Size 2014-2019 (Million US$)
Table United States Key Players Cancer Immunotherapies Revenue (2018-2019) (Million US$)
Table United States Key Players Cancer Immunotherapies Market Share (2018-2019)
Table United States Cancer Immunotherapies Market Size by Type (2014-2019) (Million US$)
Table United States Cancer Immunotherapies Market Share by Type (2014-2019)
Table United States Cancer Immunotherapies Market Size by Application (2014-2019) (Million US$)
Table United States Cancer Immunotherapies Market Share by Application (2014-2019)
Figure Europe Cancer Immunotherapies Market Size 2014-2019 (Million US$)
Table Europe Key Players Cancer Immunotherapies Revenue (2018-2019) (Million US$)
Table Europe Key Players Cancer Immunotherapies Market Share (2018-2019)
Table Europe Cancer Immunotherapies Market Size by Type (2014-2019) (Million US$)
Table Europe Cancer Immunotherapies Market Share by Type (2014-2019)
Table Europe Cancer Immunotherapies Market Size by Application (2014-2019) (Million US$)
Table Europe Cancer Immunotherapies Market Share by Application (2014-2019)
Figure China Cancer Immunotherapies Market Size 2014-2019 (Million US$)
Table China Key Players Cancer Immunotherapies Revenue (2018-2019) (Million US$)
Table China Key Players Cancer Immunotherapies Market Share (2018-2019)
Table China Cancer Immunotherapies Market Size by Type (2014-20189) (Million US$)
Table China Cancer Immunotherapies Market Share by Type (2014-2019)
Table China Cancer Immunotherapies Market Size by Application (2014-2019) (Million US$)
Table China Cancer Immunotherapies Market Share by Application (2014-2019)
Figure Japan Cancer Immunotherapies Market Size 2014-2019 (Million US$)
Table Japan Key Players Cancer Immunotherapies Revenue (2018-2019) (Million US$)
Table Japan Key Players Cancer Immunotherapies Market Share (2018-2019)
Table Japan Cancer Immunotherapies Market Size by Type (2014-2019) (Million US$)
Table Japan Cancer Immunotherapies Market Share by Type (2014-2019)
Table Japan Cancer Immunotherapies Market Size by Application (2014-2019) (Million US$)
Table Japan Cancer Immunotherapies Market Share by Application (2014-2019)
Figure Southeast Asia Cancer Immunotherapies Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Cancer Immunotherapies Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Cancer Immunotherapies Market Share (2018-2019)
Table Southeast Asia Cancer Immunotherapies Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Cancer Immunotherapies Market Share by Type (2014-2019)
Table Southeast Asia Cancer Immunotherapies Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Cancer Immunotherapies Market Share by Application (2014-2019)
Figure India Cancer Immunotherapies Market Size 2014-2019 (Million US$)
Table India Key Players Cancer Immunotherapies Revenue (2018-2019) (Million US$)
Table India Key Players Cancer Immunotherapies Market Share (2018-2019)
Table India Cancer Immunotherapies Market Size by Type (2014-2019) (Million US$)
Table India Cancer Immunotherapies Market Share by Type (2014-2019)
Table India Cancer Immunotherapies Market Size by Application (2014-2019) (Million US$)
Table India Cancer Immunotherapies Market Share by Application (2014-2019)
Figure Central & South America Cancer Immunotherapies Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Cancer Immunotherapies Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Cancer Immunotherapies Market Share (2018-2019)
Table Central & South America Cancer Immunotherapies Market Size by Type (2014-2019) (Million US$)
Table Central & South America Cancer Immunotherapies Market Share by Type (2014-2019)
Table Central & South America Cancer Immunotherapies Market Size by Application (2014-2019) (Million US$)
Table Central & South America Cancer Immunotherapies Market Share by Application (2014-2019)
Table Amgen Company Details
Table Amgen Revenue in Cancer Immunotherapies Business (2014-2019) (Million US$)
Figure Amgen Revenue Growth Rate in Cancer Immunotherapies Business (2014-2019)
Table Amgen Recent Development
Table Bristol Mayer’s Squibb Company Details
Table Bristol Mayer’s Squibb Revenue in Cancer Immunotherapies Business (2014-2019)(Million US$)
Figure Bristol Mayer’s Squibb Revenue Growth Rate in Cancer Immunotherapies Business (2014-2019)
Table Bristol Mayer’s Squibb Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Cancer Immunotherapies Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Cancer Immunotherapies Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Merck Company Details
Table Merck Revenue in Cancer Immunotherapies Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Cancer Immunotherapies Business (2014-2019)
Table Merck Recent Development
Table Takeda Company Details
Table Takeda Revenue in Cancer Immunotherapies Business (2014-2019)(Million US$)
Figure Takeda Revenue Growth Rate in Cancer Immunotherapies Business (2014-2019)
Table Takeda Recent Development
Table Global Cancer Immunotherapies Market Size by Regions (Million US$) 2019-2025
Figure Global Cancer Immunotherapies Market Size Share by Regions (2019-2025)
Figure Global Cancer Immunotherapies Market Size Share by Regions in 2025
Figure United States Cancer Immunotherapies Market Size Forecast (2019-2025)(Million USD)
Figure Europe Cancer Immunotherapies Market Size Forecast (2019-2025)(Million USD)
Figure China Cancer Immunotherapies Market Size Forecast (2019-2025)(Million USD)
Figure Japan Cancer Immunotherapies Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Cancer Immunotherapies Market Size Forecast (2019-2025)(Million USD)
Figure India Cancer Immunotherapies Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Cancer Immunotherapies Market Size Forecast (2019-2025)(Million USD)
Table Global Cancer Immunotherapies Market Size by Product (2019-2025) (Million US$)
Figure Global Cancer Immunotherapies Market Size by Product (2019-2025)
Figure Global Cancer Immunotherapies Market Size by Product in 2025
Table Global Cancer Immunotherapies Market Size by Application (2019-2025) (Million US$)
Figure Global Cancer Immunotherapies Market Size by Application (2019-2025)
Figure Global Cancer Immunotherapies Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
乳がんモノクローナル抗体の世界市場：市場規模・現状・予測 Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protei…- がんモノクローナル抗体の世界市場：インサイト・予測 The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from oth…
- 免疫チェックポイント阻害剤の世界市場：市場規模・現状・予測 Check point inhibitors are molecules that use the cosmic potential of the immune response system of the body, and its limitless influences to attack the cancer cells present inside the body, as well as avoids relapse of cancer cells. In case any relapse occurs in the body, it can easily be recognize…
- 頭頸部癌治療薬の世界市場：市場規模・現状・予測 Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands. Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private…
- 頭頸部癌治療薬の世界市場：市場規模・現状・予測 Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands. Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private…